A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant

Inclusion Criteria:

• Females of non-childbearing potential.

• Age 18 - 65 years (both inclusive) at the time of signing the informed consent.

• Body mass index (BMI) between 25.0 and 39.9 kg/m^2 (both inclusive) at screening.

• Considered to be generally healthy based on the medical history, physicalexamination, and the results of vital signs, electrocardiogram and clinicallaboratory tests performed during the screening visit, as judged by theinvestigator.

Exclusion Criteria:

• Any disorder, unwillingness or inability which in the investigator's opinion mightjeopardise participant's safety or compliance with the protocol.

• Any contraindications for the use of the oral contraception used in the studyaccording to the Microgynon Product Information.

• Use of prescription medicinal products or non-prescription drugs including anyherbal medicine known to interfere with the metabolic CYP pathways, such ashypericum (St. John's Wort), ginseng, garlic, milk thistle, and echinaceae, within 14 days before screening.

Exceptions are routine vitamins, occasional use of acetaminophen, ibuprofen and acetylsalicylic acid, or topical medication not reaching systemic circulation.

• History of major surgical procedures involving the stomach potentially affectingabsorption of trial products (e.g. subtotal and total gastrectomy, sleevegastrectomy, gastric bypass surgery) or current presence of gastrointestinalimplant.

• Presence of clinically significant gastrointestinal disorders potentially affectingabsorption of drugs or nutrients, as judged by the investigator.